Browsing by Subject "435/69.3"

Now showing items 1-6 of 6

    • Agrobacterium tumefaciens transformation of Musa species 
      Arntzen, Charles J.; May, Gregory D. (United States. Patent and Trademark Office; Texas A&M University. Libraries, 1998-08-11)
      Methods are provided for transforming Musa plants. In particular, methods for wounding meristematic Musa plant tissue to facilitate access of Agrobacterium tumefaciens comprising genetically-engineered T-DNA is provided. ...
    • DNA encoding Actinobacillus pleuropneumoniae hemolysin 
      Struck, Douglas K.; Young, Ryland F.; Chang, Yung-Fu (United States. Patent and Trademark Office; Texas A&M University. Libraries, 1997-06-24)
      This invention discloses the DNA sequences coding for the Actinobacillus pleuropneumonia hemolysin(s). It further discloses a method of producing the A. pleuropneumoniae hemolysin(s) from recombinant cells. It also provides ...
    • MHC II analog from Staphylococcus aureus 
      Hook, Magnus; Jonsson, Klas; Patti, Joseph M.; Gurusiddappa, Sivashankarappa (United States. Patent and Trademark Office; Texas A&M University. Libraries, 1997-07-15)
      Staphylococcus aureus can bind a number of different extracellular matrix proteins. Recent studies have shown that one particular Staphylococcus protein has the capacity of binding several different matrix proteins. The ...
    • Oral immunization with transgenic plants 
      Arntzen, Charles J.; Mason, Hugh S.; Haq, Tariq A. (United States. Patent and Trademark Office; Texas A&M University. Libraries, 2001-02-27)
      The oral vaccines and oral vaccine adjuvants of the present invention are produced in transgenic plants and then administered through the consumption of the transgenic plant. DNA sequences both natural and synthetic encoding ...
    • Oral immunization with transgenic plants 
      Arntzen, Charles J.; Mason, Hugh S.; Tariq, Haq A.; Clements, John D. (United States. Patent and Trademark Office; Texas A&M University. Libraries, 2002-05-28)
      The oral antigens and adjuvants of the present invention are produced in transgenic plants and then administered through the consumption of the transgenic plant. DNA sequences both natural and synthetic encoding for the ...
    • Polypeptides and polynucleotides from coagulase-negative staphylococci 
      Foster, Timothy J.; Mccrea, Kirk; Hook, Magnus A. O.; Davis, Stacey; Ni Eidhin, Deirdre; Hartford, Orla (United States. Patent and Trademark Office; Texas A&M University. Libraries, 2010-05-04)
      Methods for treating or preventing infections from coagulase-negative staphylococci using proteins and polypeptides from coagulase-negative staphylococcal bacteria such as S. epidermidis, including proteins designated SdrF, ...